The first UK COVID-19 vaccine trials started yesterday, the University of Oxford has revealed.
Researchers at the university have started testing human volunteers, with the aim of assessing whether healthy individuals can be shielded from coronavirus using the specific vaccine.
Yesterday, on Thursday 23rd April, the trial was started on two volunteers, with one receiving the vaccine and the other (who is part of the ‘control group’) receiving a widely available meningitis jab as a way of comparison.
The participants will be closely monitored for 48 hours.
The vaccine, which is known as ChAdOx1 nCoV-19, is made from a specific virus which is a weakened version of the common cold. It causes infections in chimpanzees and has been genetically-modified so it is impossible for it to reproduce and grow in humans.
There can be temporary side effects however, such as a temperature, headache or sore arm.